Containment of heart failure hospitalizations and cost by angiotensin- converting enzyme inhibitor dosage optimization

American Journal of Cardiology

Volumn 86, Issue 5, 2000, Pages 519-523

  Luzier, Aileen B ^a,c   Forrest, Alan ^a,c   Feuerstein, Stephen G ^c   Schentag, Jerome J ^a,c   Izzo Jr , Joseph L ^b,d  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Clinical Pharmacokinetics Laboratory   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; QUINAPRIL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COST CONTROL; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; PHARMACOLOGY, CLINICAL; PROSPECTIVE STUDIES;

EID: 0034284115     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01005-5     Document Type: Article

References (24)

1. Luzier A.B., Forrest A., Adelman M., Hawari F.I., Schentag J.J., Izzo J.L. Jr. Impact of angiotensin-converting enzyme inhibitors underdosing on rehospitalization rates in congestive heart failure. Am J Cardiol. 82:1998;465-469.
2. Packer M., Poole-Wilson P.A., Armstrong P.W., Cleland J.G.F., Horowicz J.D., Massie B.M., Ryden L., Thygesen K., Uretsky B.F. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 100:1999;2312-2318.
3. McDermott M.M., Lee P., Mehta S., Gheorghiade M. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure. Clin Cardiol. 21:1998;261-268.
4. Konstam MA, Dracup K, Baker DW, Bottorff MB, Brooks NH, Darcey RA, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luichi RJ, et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Rockville, MD: Agency for Healthcare Policy and Research. Clinical Practice Guideline 11 (AHCPR publication no. 94-0612), 1994.
5. Guidelines for the evaluation and management of heart failure Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee for the evaluation and management of heart failure) . Circulation. 92:1995;2764-2784.
6. The treatment of heart failure. Eur Heart J. 18:1997;736-753.
7. Smith N.L., Psaty B.M., Pitt B., Garg R., Gottdiener J.S., Heckbert S.R. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults. Arch Intern Med. 158:1998;1074-1080.
8. Young J.B., Weiner D.H., Yusuf S., Pratt C.M., Kostis J.B., Weiss M.B., Schroeder E., Guillote M. Patterns of medication use in patients with heart failure a report from the Registry of Studies of Left Ventricular Dysfunction . Scan Med J. 88:1995;14-23.
9. Philbin E.F., Andreou C., Rocco T.A., Lynch L.J., Baker S.L. Patterns of angiotensin converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 77:1996;832-838.
10. Clarke K.W., Gray D., Hampton J.R. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 71:1994;584-587.
11. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative imortance of age, sex, and medical therapy. Arch Intern Med. 156:1996;1669-1673.
12. Krumholz H.M., Wang Y., Parent E.M., Mockalis J., Petrillo M., Radford M.J. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 157:1997;2242-2247.
13. Bart B.A., Gattis W.A., Diem S.J., O'Connor C.M. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol. 79:1997;1118-1120.
14. Stafford R.S., Saglam D., Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 157:1997;2460-2464.
15. Chin M.H., Wang J.C., Zhang J.X., Lang R.M. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics. J Gen Intern Med. 12:1997;563-566.
16. Luzier A.B., Navsarikar A., Wilson M., Ashai K., Forrest A. Physician prescribing patterns of ACE inhibitors in secondary prevention post myocardial infarction. Pharmacotherapy. 19:1999;655-660.
17. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
18. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 316:1987;1429-1435.
19. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.S., Thomas I., Deedwania P.C., Ney D.E., Shavely D.B., Chang P.I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 349:1997;747-752.
20. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
21. Gattis W.A., Hasselblad V., Whellan D.J., O'Connor C.M. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med. 159:1999;1939-1945.
22. Houghton A.R., Cowley A.J. Why are angiotensin-converting enzyme inhibitors underutilized in the treatment of heart failure by general practitioners? Int J Cardiol. 59:1997;7-10.
23. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol. 28:1996;1323-1327.
24. Sheiner M.A., Kimmel S.E. Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care? J Gen Intern Med. 12:1997;581-582.